ADC Therapeutics (ADCT) EPS (Basic) (2020 - 2026)
ADC Therapeutics (ADCT) posted EPS (Basic) of -$0.21 for Q1 2026, up 28.76% sequentially from -$0.3 in Q3 2025, and up 40.6% YoY from -$0.15 in Q1 2025.
ADC Therapeutics (ADCT) EPS (Basic) (2020 - 2026) Analysis & Trends
ADC Therapeutics has reported EPS (Basic) for 7 years, with the latest figure at -$0.21 in Q1 2026.
- Quarterly EPS (Basic) rose 40.6% year-over-year to -$0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.85 (up 23.21% YoY) and the FY2022 annual result came in at -$1.95, up 35.03% from the prior year.
- EPS (Basic) rose to -$0.21 in Q1 2026 per ADCT's latest filing, from -$0.3 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.21 in Q1 2026 and troughed at -$0.84 in Q2 2022.
- A 5-year average of -$0.47 and a median of -$0.46 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) jumped 67.71% in 2022, then sank 239.09% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.23 in 2022, then sank by 137.11% to -$0.55 in 2023, then increased by 24.29% to -$0.42 in 2024, then climbed by 28.0% to -$0.3 in 2025, then grew by 28.76% to -$0.21 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.21, -$0.3, and -$0.5 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - | 0.18 |
| 10 | ADC Therapeutics | 152.30 Mn | -66.80 Mn | 17.14 Mn | -0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.21 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.50 |
| Mar 31, 2025 | -0.36 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -0.38 |
| Mar 31, 2024 | -0.56 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.59 |
| Mar 31, 2023 | -0.74 |
| Dec 31, 2022 | -0.23 |
| Sep 30, 2022 | -0.65 |
| Jun 30, 2022 | -0.84 |
| Mar 31, 2022 | -0.22 |
| Dec 31, 2021 | -0.46 |
| Sep 30, 2021 | -0.93 |
| Jun 30, 2021 | -0.95 |
| Mar 31, 2021 | -0.67 |
| Dec 31, 2020 | -0.86 |